Keep the cat, change the care pathway: A transformational approach to managing Fel d 1, the major cat allergen
- PMID: 31498459
- PMCID: PMC7156987
- DOI: 10.1111/all.14013
Keep the cat, change the care pathway: A transformational approach to managing Fel d 1, the major cat allergen
Abstract
Background: Allergies to cats are the most common animal-origin allergy, and affect approximately 1 in 5 adults worldwide. The prevalence of allergy to furry animals has been increasing, and allergy to cats is a major risk factor for the development of asthma and rhinitis. The diagnosis of cat allergy is now well established. The exact significance of component-resolved diagnosis in the diagnosis of cat allergy remains to be fully understood. Allergen avoidance is effective but often has a psychologic impact. Allergen immunotherapy is not well demonstrated. There is a need for innovative approaches to better manage cat allergens. Next-generation care pathways for asthma and rhinitis will define the place of cat allergen avoidance.
Methods and results: This manuscript, based on content presented at the European Academy of Allergy and Clinical Immunology Congress 2019, provides information on the prevalence and impact of cat allergies and the molecular biology of Fel d 1, the major cat allergen.
Discussion: The authors present the scientific basis of a novel care pathway that utilizes anti-Fel d 1 IgY antibodies to safely and effectively neutralize Fel d 1 after its production by the cat but before human exposure.
Conclusion: Efficacy of a feline diet with an egg product ingredient containing anti-Fel d 1 IgY antibodies was demonstrated in vitro, ex vivo, and in vivo, and further validated by a pilot exposure study involving cat-allergic human participants.
Keywords: Fel d 1; allergens; anti-Fel d1 IgY; blocking antibodies; cat allergies.
© 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
Fel d1 Blocking Antibodies: A Novel Method to Reduce IgE-Mediated Allergy to Cats.J Immunol Res. 2021 Jun 19;2021:5545173. doi: 10.1155/2021/5545173. eCollection 2021. J Immunol Res. 2021. PMID: 34250096 Free PMC article.
-
Anti-Fel d1 immunoglobulin Y antibody-containing egg ingredient lowers allergen levels in cat saliva.J Feline Med Surg. 2019 Oct;21(10):875-881. doi: 10.1177/1098612X19861218. Epub 2019 Jul 16. J Feline Med Surg. 2019. PMID: 31310154 Free PMC article.
-
Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects.J Allergy Clin Immunol. 2019 Jul;144(1):193-203. doi: 10.1016/j.jaci.2019.01.050. Epub 2019 May 2. J Allergy Clin Immunol. 2019. PMID: 31056187
-
Why is pet (cat/dog) allergen immunotherapy (AIT) such a controversial topic? Current perspectives and future directions.Eur Ann Allergy Clin Immunol. 2024 Jul;56(4):188-191. doi: 10.23822/EurAnnACI.1764-1489.330. Epub 2024 Feb 13. Eur Ann Allergy Clin Immunol. 2024. PMID: 38348623 Review.
-
The major cat allergen, Fel d 1, in diagnosis and therapy.Int Arch Allergy Immunol. 2010;151(4):265-74. doi: 10.1159/000250435. Epub 2009 Oct 22. Int Arch Allergy Immunol. 2010. PMID: 19844127 Review.
Cited by
-
Human allergy to cats: A review of the impact on cat ownership and relinquishment.J Feline Med Surg. 2022 Jan;24(1):43-52. doi: 10.1177/1098612X211013016. Epub 2021 Oct 8. J Feline Med Surg. 2022. PMID: 34622709 Free PMC article. Review.
-
Digital transformation of health and care to sustain Planetary Health: The MASK proof-of-concept for airway diseases-POLLAR symposium under the auspices of Finland's Presidency of the EU, 2019 and MACVIA-France, Global Alliance against Chronic Respiratory Diseases (GARD, WH0) demonstration project, Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing.Clin Transl Allergy. 2020 Jun 19;10:24. doi: 10.1186/s13601-020-00321-2. eCollection 2020. Clin Transl Allergy. 2020. PMID: 32577216 Free PMC article. Review.
-
The Major Cat Allergen Fel d 1 Binds Steroid and Fatty Acid Semiochemicals: A Combined In Silico and In Vitro Study.Int J Mol Sci. 2020 Feb 18;21(4):1365. doi: 10.3390/ijms21041365. Int J Mol Sci. 2020. PMID: 32085519 Free PMC article.
-
The holo beta-lactoglobulin lozenge reduces symptoms in cat allergy-Evaluation in an allergen exposure chamber and by titrated nasal allergen challenge.Clin Transl Allergy. 2023 Jul;13(7):e12274. doi: 10.1002/clt2.12274. Clin Transl Allergy. 2023. PMID: 37488734 Free PMC article.
-
Hypoallergenic animals: A promise of hope for allergic patients?Allergol Select. 2024 Mar 21;8:64-69. doi: 10.5414/ALX02454E. eCollection 2024. Allergol Select. 2024. PMID: 38549813 Free PMC article. Review.
References
-
- Morris DO. Human allergy to environmental pet danders: a public health perspective. Vet Derm. 2010;21:441‐449. - PubMed
-
- Suzuki S, Nwaru BI, Ekerljung L, et al. Characterization of sensitization to furry animal allergen components in an adult population. Clin Exp Allergy. 2019;49:495‐505. - PubMed
-
- Bousquet PJ, Chinn S, Janson C, Kogevinas M, Burney P, Jarvis D. Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I. Allergy. 2007;62:301‐309. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous